title: Studies on cocktails of 31-kDa, 36-kDa and 51-kDa antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis.
abstract: A substantial number of antigens of Leishmania donovani have been described in the past. However, identifying candidate antigens is not enough. Appropriate antigen delivery to induce the right type of immune response against leishmaniasis (i.e. induction of a strong antigen-specific Th1 type of immune response) is another crucial component of an effective vaccine. Therefore, 'cocktail' vaccines are proposed based on the assumption that such cocktails will show enhanced efficacy. Studies have been carried out on LD31 and LD51 polypeptides from L. donovani promastigotes, which have proven to be potential vaccine candidates. This study was designed to check the protective efficacy of various cocktails of low molecular weight antigens alone and along with saponin as adjuvant. Mice were sacrificed on different post-challenge days for evaluation of parasite load and other immunological parameters. Protective efficacy of different vaccine formulations was revealed by significant decline in parasite burden and increased DTH Delayed Type Hypersenstivity responses. The antibody response was of IgG type with elevated IgG2a and decreased production of IgG1, whereas cytokine levels pointed towards the generation of protective Th1 type of immune response. Among all vaccine formulations, cocktail of 31+51+saponin was found to be highly immunogenic and imparted maximum protection.
authors.affiliation: Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, India.
authors.forename: H
authors.initials: H
authors.lastname: Kaur
authors.forename: A
authors.initials: A
authors.lastname: Thakur
authors.forename: S
authors.initials: S
authors.lastname: Kaur
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000917:Antibody Formation; D000953:Antigens, Protozoan / Q000008:administration & dosage / Q000276:immunology*; D016207:Cytokines / Q000276:immunology; D005260:Female; D007074:Immunoglobulin G / Q000276:immunology; D007893:Leishmania donovani / Q000276:immunology*; D054332:Leishmaniasis Vaccines / Q000008:administration & dosage / Q000276:immunology*; D007898:Leishmaniasis, Visceral / Q000276:immunology* / Q000517:prevention & control; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D059208:Parasite Load; D012503:Saponins / Q000008:administration & dosage
chemical_list: D000276:Adjuvants, Immunologic; D000953:Antigens, Protozoan; D016207:Cytokines; D007074:Immunoglobulin G; D054332:Leishmaniasis Vaccines; D012503:Saponins
keywords: 31kDa; 36 kDa; 51 kDa; immune response; vaccines; visceral leishmaniasis